An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00402181 · COMPLETED
Trial details
- NCT number
- NCT00402181
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2009-07-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.